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The NS1 protein of influenza A virus binds not only to poly(A) and a stem-bulge region in U6 small nuclear RNA (snRNA),
but also to double-stranded (ds) RNA. Binding assays with NS1 protein mutants established that the previously identified
RNA-binding domain of the NS1 protein is required for binding to ds RNA as well as for binding to poly(A) and U6 snRNA.
In addition, dsRNA competed with U6 snRNA for binding to the NS1 protein, consistent with both RNAs sharing the same
binding site on the protein. As a consequence of its binding to dsRNA, the NS1 protein blocks the activation of the dsRNA-
activated protein kinase (PKR) in vitro. This kinase phosphorylates the a subunit of eukaryotic translation initiation factor 2
(eIF-2a), leading to a decrease in the rate of initiation of translation. Assays using purified PKR and purified eIF2 demonstrated
that the NS1 protein blocks the dsRNA activation of PKR, and experiments using reticulocyte extracts showed that the NS1
protein blocks the inhibition of translation caused by dsRNA activation of PKR. The implications of these results for control
mechanisms occurring in influenza virus-infected cells are discussed. q 1995 Academic Press, Inc.
INTRODUCTION tada and Fukuda, 1992; present study) and as a conse-
quence blocks the activation of the dsRNA-activated pro-
The NS1 protein of influenza A virus is a small non- tein kinase (PKR) in vitro (present study). PKR phosphory-
structural RNA-binding protein (Qiu and Krug, 1993; Qiu lates the a subunit of the eukaryotic translation initiation
et al., 1995). Like other RNA binding proteins, the NS1 factor 2 (eIF2a) (Galabru and Hovanessian, 1987; Sam-
protein regulates posttranscriptional steps in gene ex- uel, 1993). This phosphorylation has been shown to lead
pression by interacting with specific RNA sequences. to a decrease in the rate of initiation of translation (re-
The NS1 protein has been shown to function in two post- viewed in Hershey, 1991; Merrick, 1992; Rhoads, 1993).
transcriptional steps. First, this protein inhibits the nu- During initiation eIF2 forms a ternary complex with GTP
clear export of poly(A)-containing mRNAs (Alonso-Caplen and initiator met tRNA. After initiation is completed, eIF2
et al., 1992; Fortes et al., 1994; Qian et al., 1994; Qiu and is released from the ribosomes in the form of eIF2-GDP.
Krug, 1993). To carry out this function, the NS1 protein The exchange factor eIF2B then replaces the GDP asso-
recognizes and binds to the 3* poly(A) sequence of mRNA ciated with eIF2 with GTP, thereby regenerating the func-
(Qiu and Krug, 1994). In addition, the NS1 protein inhibits tional form of eIF2, namely eIF2-GTP. However, when the
pre-mRNA splicing (Fortes et al., 1994; Lu et al., 1994; a subunit of eIF2 is phosphorylated, this exchange does
Qiu et al., 1995). Unlike other proteins that regulate splic- not occur and eIF2B is trapped in a stable complex with
ing, the NS1 protein binds to a key spliceosomal RNA, eIF2, causing a limitation in functional eIF2-GTP. Be-
U6 small nuclear RNA (snRNA), to carry out its function cause virus infection can lead to the activation of PKR
(Qiu et al., 1995). The binding site on U6 snRNA is a and the consequent reduction in the rate of protein syn-
purine-containing bulge imbedded in a stem structure. thesis, various viruses have evolved mechanisms to pre-
In addition to an RNA-binding domain, the NS1 protein vent PKR activation (reviewed in Katze, 1992; Mathews,
has a second functional domain, called an effector do- 1993; Samuel, 1993). The present study indicates that
main, that is presumed to interact with host cell nuclear one of the mechanisms employed by influenza virus likely
proteins (Qian et al., 1994). involves the NS1 protein.
Here we present evidence indicating that the NS1 pro-
tein regulates another posttranscriptional step. The NS1
MATERIALS AND METHODSprotein also binds to double-stranded RNA (dsRNA) (Ha-
RNA-binding assays. NS1 wild-type and mutant pro-
teins were expressed as glutathione S-transferase1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 908-235-4880. E-mail: KRUG@MBCL.RUTGERS.EDU. (GST)–NS1 fusions and were purified as previously de-
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scribed (Qiu and Krug, 1994). The NS1 protein was then analyzed by electrophoresis on a SDS-containing,
10% polyacrylamide gel.cleaved from the fusion by treatment with protease factor
Xa. Double-stranded reovirus RNA (kindly provided by
RESULTSAaron Shatkin) was labeled using T4 RNA ligase and
[32P]pCp (final specific activity of RNA, 6000 cpm/ng). The RNA-binding domain of the NS1 protein binds to
For generating sense and antisense transcripts of the double-stranded RNA
pGEM1 polylinker, the pGEM 1 plasmid was cut at EcoRI
The NS1 protein binds to two RNA sequences, poly(A)and HindIII sites and transcribed by both Sp6 and T7
and the stem-bulge in U6 snRNA, to carry out its functionsRNA polymerases in the presence of [a32P]UTP. The tran-
in nuclear mRNA export and pre-mRNA splicing, respec-scripts (in 10 mM HEPES, pH 7.6; 50 mM NaCl) were
tively (Qiu and Krug, 1993; Qiu et al., 1995). Both of theseheated at 907 for 2 min and were allowed to anneal to
RNA sequences are highly ordered. The most highly or-each other by slow cooling to room temperature. 32P-
dered RNA sequence would be expected to be dsRNA.labeled U6 snRNA was synthesized as described pre-
We determined whether the NS1 protein also bound spe-viously (Qiu et al., 1995). For the binding experiments,
cifically to dsRNA, particularly in light of a previous reportthe indicated amount of the NS1 protein and the target
that this was the case (Hatada and Fukuda, 1992). Au-RNA were incubated for 20 min on ice in 20 ml binding
thentic dsRNA, reovirus genomic RNA, labeled at the 3*reactions containing 43 mM Tris–HCl, pH 8.0, 50 mM
end, was incubated with increasing concentrations of theKCl, 8% glycerol, 2.5 mM dithiothreitol, 50 mg/ml Esche-
NS1 protein, and the mixtures were analyzed by nativerichia coli tRNA; and 0.5 units/ml RNasin (Qiu and Krug,
gel electrophoresis (Fig. 1). In the presence of 0.05 mM1994). The protein–RNA complexes were resolved from
of the NS1 protein, almost all of the ds reovirus RNAunbound RNA by electrophoresis on 6% nondenaturing
segments were shifted to more slowly migrating RNA–polyacrylamide. The running buffer contained 50 mM
protein complexes. As the NS1 protein concentrationTris–borate, pH 8.0; 1 mM EDTA. Gels were electropho-
was increased further, the complexes increased in size,resed at 150 V for 3 hr at 47 or, for the reovirus experi-
indicating that multiple NS1 proteins were binding to thements, 350 V for 18 hr at 47. The gels were then dried
ds reovirus RNAs. This NS1 protein titration curve isand autoradiographed.
similar to that obtained previously with U6 snRNA (QiuIn vitro translation assays. Nuclease-treated rabbit re-
et al., 1995).
ticulocyte extracts were programmed with luciferase
To establish that the previously identified RNA binding
mRNA, which was usually generated in situ by T7 RNA
domain of the NS1 protein (Qian et al., 1994) was re-
polymerase transcription of the luciferase gene (TNT
quired for the binding of dsRNA, NS1 proteins with muta-
coupled reticulocyte system, Promega). The reaction mix- tions in the RNA binding domain—NSm2 and NSm3—
tures contained [35S]methionine, an amino acid mixture were used in the gel shift assay. These mutant NS1
(minus methionine), T7 RNA polymerase, and DNA en- proteins do not bind to either poly(A) or U6 snRNA (Qian
coding luciferase mRNA, and translation was carried out et al., 1994; Lu et al., 1994; Qiu et al., 1995). Neither of
for 60 min at 307. The amount of luciferase synthesized the two mutant NS1 proteins (at the high concentration
was determined by gel electrophoresis on SDS-con- of 0.4 mM ) bound to ds reovirus RNA (Fig. 2A). The same
taining 12.5% polyacrylamide gels, followed by fluoro- results were obtained with another dsRNA, one that was
graphy. generated by annealing the sense and antisense tran-
Assay of PKR activation. PKR was purified using an scripts of the polylinker of the pGEM1 plasmid (Fig. 2B).
immunoaffinity column (Galabru and Hovanessian, 1987), This small dsRNA of 29 base pairs formed a single dis-
and purified eIF2 was kindly provided by Leonard Jeffer- crete RNA–protein complex when incubated with wild-
son. Prior to the activation assay, ds reovirus RNA (final type NS1 protein (0.4 mM ). In contrast, no detectable
concentration of 0.01 mg/ml) was incubated with the indi- complex was formed in the presence of the same con-
cated amount of wild-type NS1 protein or of the NS1D1 centration of the NSm2, NSm3, or NSm4 RNA-binding
deletion mutant under activation conditions (Lee et al., mutant proteins, or the NSD1 protein containing a dele-
1994) for 20 min at 307. Two controls were run, one with- tion of the RNA-binding domain. These results indicate
out both ds reovirus RNA and the NS1 protein and one that the previously identified wild-type RNA-binding do-
without the NS1 protein but containing ds reovirus RNA. main of the NS1 protein (Qian et al., 1994) is required for
After this preincubation, purified PKR (1.3 ng), purified binding to dsRNA as well as for binding to poly(A) and
eIF-2 (60 ng), and [g32P]ATP (3000 Ci/mmol) were added, U6 snRNA.
and the reaction mixtures were incubated for an addi- Only dsRNA and not single-stranded RNA competed
tional 15 min at 307. The reactions were terminated by with a dsRNA target for the binding domain of the NS1
the addition of the SDS-containing gel buffer, followed protein (Fig. 3A). Thus, unlabeled ds poly(I):(C) (1.5 mg/
ml or 0.6 nM ) efficiently blocked the binding of the 29by boiling for 5 min. The phosphorylated proteins were
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FIG. 1. The influenza virus NS1 protein binds to ds reovirus RNA.
32P-labeled ds reovirus RNA (16 ng, approximately 0.5 nM ) was incu-
bated with increasing concentrations of the NS1 protein (lanes 2–7),
or with GST (0.4 mM ) (lane 8), and the mixtures were subjected to
nondenaturing gel electrophoresis. Lane 1, P, reovirus RNA alone. L,
M, S, large, medium, and small ds reovirus RNA segments, respectively.
base pair ds pGEM1 RNA (1.0 mM ) to the NS1 protein
(0.4 mM ) (lane 3), whereas the same concentration of
unlabeled single-stranded poly(I) or poly(C) had no effect
on the binding of ds pGEM1 RNA (lanes 4 and 5). Be-
FIG. 2. Wild-type RNA-binding domain of the NS1 protein is requiredcause each molecule of ds poly (I):(C) contains about 65
for binding to ds RNA. (A) 32P-labeled ds reovirus RNA (approximatelytimes the number of base pairs as the ds pGEM1 RNA,
0.5 nM ) was incubated with 0.4 mM wild-type NS1 protein (lane 2), GST
it can be presumed that in this competition assay the (lane 3), NSm2 mutant protein (lane 4), or NSm3 mutant protein (lane
number of binding sites in poly(I):(C) at 0.6 mM was about 5), and the mixtures were subject to nondenaturing gel electrophoresis.
Lane 1, P, reovirus RNA alone. L, M, S, large, medium, and small ds40 times that in ds pGEM1 RNA at 1.0 nM. Unlabeled ds
reovirus RNA segments, respectively. (B) 32P-labeled ds pGEM1 RNARNA (reovirus RNA) also competed with a different la-
(1.0 nM ) was incubated with 0.4 mM wild-type NS1 protein (lane 2),beled target RNA, U6 snRNA (at 1.0 nM ), for binding to
NSm2 mutant protein (lane 3), NSm3 mutant protein (lane 4), NSm4
the NS1 protein (Fig. 3B). Because U6 snRNA most likely mutant proteins (lane 4), or NSD1 deletion mutant protein (lane 5),
contains a single binding site for the NS1 protein (Qiu and the mixtures were subjected to nondenaturing gel electrophoresis.
Lane 1, P, ds pGEM1 RNA alone. pGEMT7 and pGEMSp6, the unan-et al., 1995), the lowest level of unlabeled ds reovirus
nealed sense and antisense single-stranded RNAs.RNA used in this competition assay (1.25 mg/ml or about
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FIG. 3. Double-stranded RNA competes with both double-stranded RNA (A) and U6snRNA (B) for binding to the NS1 protein. (A) 32P-labeled ds
pGEM1 RNA (1.0 nM ) was mixed with 1.5 mg/ml ds poly (I):(C) (approximately 2000 base pairs) (lane 3), single-stranded poly (I) (lane 4), or single-
stranded poly (C), followed by the addition of 0.4 mM NS1 protein. After incubation, the mixtures were subjected to nondenaturing gel electrophoresis.
Lane 1, ds pGEM1 RNA in the absence of the NS1 protein. Lane 2, ds pGEM1 RNA incubated with the NS1 protein in the absence of a competitor
RNA. (B) 32P-labeled U6 snRNA (1.0 nM ) was mixed with the indicated concentrations of ds reovirus RNA (lanes 3–5), followed by the addition of
0.4 mM NS1 protein. The mixtures were subjected to nondenaturing gel electrophoresis. Lane 1, U6 snRNA in the absence of the NS1 protein. Lane
2, U6 snRNA incubated with the NS1 protein in the absence of a competitor RNA.
0.6 nM ) contained approximately 60 times more binding occurred with 0.1 mM NS1 protein, and complete restora-
tion occurred with 0.2 mM NS1 protein. Translation resto-sites (assuming 30 base pairs per binding site) than in
U6 snRNA at 1.0 nM. These results indicate that the NS1 ration required a wild-type RNA binding domain in the
NS1 protein (Fig. 4C). NS1 proteins containing either aprotein binding sites for U6 snRNA and for ds RNA are
the same or at least overlapping, consistent with the point mutation in the RNA-binding domain (NSm2) or a
deletion of the RNA-binding domain (NS1D1) did not re-mutant data presented above.
store translation. The most efficient restoration of transla-
tion occurred when the NS1 protein was preincubatedThe NS1 protein blocks the inhibition of translation
with ds reovirus RNA prior to the addition of the reticulo-caused by dsRNA
cyte extract (Fig. 4D). When the NS1 protein was added
The addition of dsRNA to cell-free extracts has been at the same time as the reticulocyte extract, the restora-
shown to activate PKR which phosphorylates eIF-2a, tion was considerably reduced. No detectable restoration
leading to the inhibition of protein synthesis (reviewed occurred when the NS1 protein was added 5 min after
in Rhoads, 1993; Samuel, 1993). The effect of increasing the reticulocyte extract. These results indicate that the
concentrations of ds reovirus RNA on protein synthesis NS1 protein, by binding to dsRNA via its RNA-binding
catalyzed by reticulocyte extracts is shown in Fig. 4A. domain, most likely blocks the activation of PKR and the
Translation was programmed by luciferase mRNA gener- subsequent inhibition of translation. Preincubation of the
ated by transcription during the translation reaction. The dsRNA with the NS1 protein would enable all the dsRNA
same results were obtained in all the translation experi- to be sequestered in complexes with the NS1 protein
ments when luciferase mRNA was added directly to the prior to the introduction of the unactivated PKR present
translation reaction. Relative to the amount of translation in the reticulocyte extract.
in the absence of dsRNA (lane 7), the addition of increas-
ing amounts of dsRNA, from 0.001 to 1.0 mg/ml, caused The NS1 protein blocks the activation of PKR
increasing amounts of inhibition of translation (lanes 1 –
5). When the dsRNA concentration was increased to 10 To prove directly that the NS1 protein blocked the acti-
vation of PKR, we determined the effect of this proteinmg/ml, translation inhibition was slightly reversed (lane
6). Reversal of inhibition at high DNA concentrations is on the dsRNA activated phosphorylation of purified PKR
and its purified substrate eIF2a (Fig. 5). The phosphatecharacteristic of PKR (Samuel, 1993).
Preincubation of the NS1 protein with ds reovirus RNA donor was [g32P]ATP. In the absence of ds reovirus RNA,
neither PKR nor the eIF2a substrate was phosphorylated(0.1 mg/ml) prevented the inhibition of translation caused
by this dsRNA (Fig. 4B). Partial restoration of translation (lane 1). The addition of a low level of ds reovirus RNA
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teins (Qian et al., 1994). The NS1 protein RNA-binding
domain has now been shown to bind to three different
RNAs, poly(A), a stem-bulge region in U6 snRNA, and
double-stranded RNA (Hatada and Fukuda, 1992; Qiu and
Krug, 1993; Qiu et al., 1995; present study). Mutations in
the NS1 RNA-binding domain eliminate binding activity
with all three RNAs, and the three RNAs compete with
each other for binding to the NS1 protein (Qian et al.,
1994; Lu et al., 1994; Qiu et al., 1995; present study),
indicating that the same domain of the protein likely
binds to all three RNAs. Are there common features in
these three RNAs that are recognized by the RNA-binding
domain of the NS1 protein? One possibility is that struc-FIG. 4. The NS1 protein blocks the inhibition of translation caused
tures similar to the A form of dsRNA are present in bothby ds RNA. (A) Increasing concentrations of ds reovirus RNA were
mixed with 5 ml of nuclease-treated reticulocyte extracts (lanes 1–6) poly(A) and the stem-bulge of U6 snRNA, and that these
and incubated for 10 min at 307. As a control (c) the extract was incu- structures are recognized by the NS1 protein. To eluci-
bated in the absence of ds reovirus RNA (lane 7). The reaction mixtures date how the NS1 protein recognizes and binds to itswere then supplemented with translation components as described
RNA targets, we have initiated structural studies of theunder Materials and Methods. After incubation for 60 min at 307, the
NS1 protein and of its complex with a target RNA. It isproteins were analyzed by SDS gel electrophoresis. (B) Reovirus RNA
(0.1 mg/ml) was incubated with 0.2 mM GST (lane 3), 0.1 mM NS1 protein likely that the mode of binding of the NS1 protein to its
(lane 4), or 0.2 mM NS1 protein (lane 5) for 10 min at 307. As a control, RNA targets will differ from that of previously reported
no protein was added to the reovirus RNA (lane 2). Reticulocyte extract ds RNA-binding proteins, because the NS1 protein RNA-was added for another incubation at 307 for 10 min. These mixtures
binding domain does not share any significant homologywere then supplemented with the translation components, and transla-
with the RNA-binding domains of these other ds RNA-tion was carried out for 60 min at 307. Lane 1, no ds reovirus RNA was
added to the reticulocyte extract. (C) Reovirus RNA (0.1 mg/ml) was binding proteins (St. Johnston et al., 1992; Green and
incubated with 0.2 mM wild-type NS1 protein (lane 3), NS1D1 deletion Mathews, 1992).
mutant protein (lane 4), or NS1m2 mutant protein (lane 5) for 10 min Previous studies have indicated that during influenzaat 307. As a control, no protein was added to the reovirus RNA (lane
virus infection PKR is first activated by viral ds RNAs2). This was followed sequentially by a 10-min incubation at 307 with
(Katze, 1992). Subsequently PKR is suppressed by pro-reticulocyte extract and then a translation reaction for 60 min at 307.
Lane 1, no ds reovirus RNA was added to the reticulocyte extract. (D) cesses requiring viral gene expression, thereby main-
The NS1 protein (0.2 mM ) was either preincubated for 10 min with the taining high levels of protein synthesis. A 58-kDa cellular
reovirus RNA (0.1 mg/ml) as described above (lane 3), added to the
protein, which was purified from virus-infected cells, hasreticulocyte extract at the same time as the reovirus RNA (lane 4), or
been shown to inhibit the phosphorylation of eIF2a by5 min after the reovirus RNA (lane 5). As a control, no protein was
added to the reovirus RNA (lane 2). After a total of 10 min incubation
with the reticulocyte extract, the translation components were added
for a subsequent incubation for 60 min at 307. Lane 1, no ds reovirus
RNA added to the reticulocyte extract.
(0.01 mg/ml) caused a dramatic stimulation of the phos-
phorylation of both PKR and eIF2a (lane 2). Preincubation
of the ds reovirus RNA with wild-type NS1 protein com-
pletely blocked the phosphorylation of both PKR and
eIF2a (lanes 3–5). In contrast, the NS1 protein containing
a deletion of the RNA-binding domain (NS1D1) did not
inhibit the phosphorylation of PKR and eIF2a (lanes 6–8).
These results demonstrate directly that the NS1 protein
blocks the dsRNA activation of PKR. As a consequence FIG. 5. The NS1 protein blocks the activation of PKR. Double-
this kinase does not autophosphorylate and does not stranded reovirus RNA (0.01 mg/ml) was incubated for 20 min at 307 in
the absence of added protein (lane 2), in the presence of the indicatedphosphorylate eIF2a.
concentration of wild-type NS1 protein (lanes 3–5), or in the presence
of the indicated concentration of the NS1D1 deletion mutant protein
DISCUSSION (lanes 6–9). Purified PKR and eIF-2, and [g32P]ATP were added and
the reaction mixtures were then incubated for 15 min at 307. As a
The influenza virus NS1 protein has two functional do- control, neither ds reovirus RNA nor the NS1 protein was added to the
mains, an RNA-binding domain and an effector domain PKR activation reaction (lane 1). Phosphorylated proteins were resolved
by gel electrophoresis.that is presumed to interact with host cell nuclear pro-
/ m4655$7600 11-09-95 19:10:09 viras AP-Virology
227BINDING OF THE INFLUENZA VIRUS NS1 PROTEIN
PKR, including already activated PKR (Lee et al., 1990, block this activation, thereby increasing the rate of initia-
tion of translation of the plasmid-derived mRNAs. In fact,1994). Evidence has been presented that the virus acti-
vates the 58-kDa cellular protein by dissociating it from one of the studies cited above (Luna et al., 1995) showed
that a major effect of the NS1 protein was to increasean inhibitory cellular factor (Lee et al., 1992). The results
in the present report indicate that there is likely a second the rate of translation initiation of the plasmid-derived
mRNAs in the transfected cells. The blockage of PKRmechanism for inhibiting PKR, namely blocking activation
of this kinase by sequestering viral dsRNAs in complexes activation by the NS1 protein would be expected to favor
the translation of viral mRNAs versus cellular mRNAs ifwith the viral NS1 protein. Our in vitro results show that
the NS1 protein binds to dsRNA and that this binding this blockage were partial rather than complete. In this
situation some phosphorylation of eIF2a would continueblocks the dsRNA from activating the PKR kinase. As a
consequence, eIF-2a was not phosphorylated and pro- to occur, but the amount of phosphorylated eIF2a would
not exceed the amount of the eIF-2B recycling factor.tein synthesis was not inhibited. Based on these results
our working hypothesis is that in infected cells the NS1 Consequently, translation initiation would not cease, but
rather would continue at a reduced rate. Under theseprotein, which is predominantly in the nucleus (Lazaro-
witz et al., 1971; Compans, 1973; Krug and Etkind, 1973), conditions those mRNAs that are better initiators of trans-
lation (‘‘better mRNAs’’) would be predicted to interactsequesters viral dsRNAs in the nucleus, where these
molecules would be expected to be generated as a by- preferentially with the limiting amount of eIF-2-containing
initiation complexes on ribosomes (Lodish, 1974, 1976).product of viral RNA transcription and replication (Krug
et al., 1989). This would block the dsRNA activation of In fact, we most likely achieved these very conditions in
earlier experiments, and demonstrated that under thesePKR in the cytoplasm. If the NS1 protein does carry out
this function in infected cells, then influenza virus would conditions influenza viral mRNAs behaved as ‘‘better
mRNAs,’’ i.e., they were translated preferentially versuslikely mount a two pronged attack against PKR, blocking
the activation of the kinase and inhibiting the activity of adenovirus and cellular mRNAs (Katze et al., 1984, 1986).
Further experiments are needed to clarify the preciseany kinase that happens to be activated (Lee et al., 1990,
1992; present study). Vaccinia virus also apparently uti- role of the NS1 protein in translation in infected cells.
lizes an analogous two pronged attack, a dsRNA-binding
protein that prevents activation of the kinase and a viral ACKNOWLEDGMENTS
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